Your browser doesn't support javascript.
loading
Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration.
Akturk, Halis Kaan; Herrero, Pau; Oliver, Nick; Wise, Haley; Eikermann, Emma; Snell-Bergeon, Janet; Shah, Viral N.
Afiliación
  • Akturk HK; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Herrero P; Department of Electrical and Electronic Engineering, Imperial College London, London, United Kingdom.
  • Oliver N; Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, United Kingdom.
  • Wise H; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Eikermann E; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Snell-Bergeon J; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Shah VN; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Diabetes Technol Ther ; 24(10): 749-753, 2022 10.
Article en En | MEDLINE | ID: mdl-35653736
ABSTRACT

Aims:

To determine if a longer duration of continuous glucose monitoring (CGM) sampling is needed to correctly assess the quality of glycemic control given different types of data loss. Materials and

Methods:

Data loss was generated in two different methods until the desired percentage of data loss (10-50%) was achieved with (1) eliminating random individual CGM values and (2) eliminating gaps of a predefined time length (1-5 h). For CGM metrics, days required to cross predetermined targets for median absolute percentage error (MdAPE) for the different data loss strategies were calculated and compared with current international consensus recommendation of >70% of optimal data sampling.

Results:

Up to 90 days of CGM data from 291 adults with type 1 diabetes were analyzed. MdAPE threshold crossing remained virtually constant for random CGM data loss up to 50% for all CGM metrics. However, the MdAPE crossing threshold increased when losing data with longer gaps. For all CGM metrics assessed in our study (%T70-180, %T < 70, %T < 54, %T > 180, and %T > 250), up to 50% data loss in a random manner did not cause any significant change on optimal sampling duration; however, >30% of data loss in gaps up to 5 h required longer optimal sampling duration.

Conclusions:

Optimal sampling duration for CGM metrics depends on percentage of data loss as well as duration of data loss. International consensus recommendation for 70% CGM data adequacy is sufficient to report %T70-180 with 2 weeks of data without large data gaps.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Límite: Adult / Humans Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Hipoglucemia Límite: Adult / Humans Idioma: En Revista: Diabetes Technol Ther Asunto de la revista: ENDOCRINOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos